Advancing Clinical Therapeutics Globally For Hiv/aids And Other Infections
Clinical trials sponsored by Advancing Clinical Therapeutics Globally For Hiv/aids And Other Infections, explained in plain language.
-
Could antibodies keep HIV in check without daily pills?
Disease control OngoingThis study tests whether giving two lab-made antibodies can safely help control HIV when people stop their regular antiretroviral therapy for a short time. About 32 adults with HIV in Sub-Saharan Africa will receive either the antibodies or a placebo by IV infusion. The goal is t…
Phase: PHASE1 • Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
HIV study seeks blanket consent for future genetic testing on stored samples
Knowledge-focused OngoingThis study asks people who have taken part in HIV clinical trials for permission to use their stored blood and tissue samples in future research, including genetic tests. The goal is to have a broad consent so scientists can study these samples for many years to come. No new trea…
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections • Aim: Knowledge-focused
Last updated May 26, 2026 10:46 UTC